Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

RGO.DE

Strong Buy

Regeneron Pharmaceuticals, Inc. · Healthcare · United States · $84.9B · Avg Vol: $28K/d

88
StockRank
Get insider-trade alerts
Q
75
V
46
M
66
P/E (TTM)
20.3x
ROE
14.0%
D/E
0.1x
Dividend %
0.5%
Dir. Trades · 180d
None →
Buybacks · 180d
None →
Loading 1Y...
PRICE (1Y)+17.3%
664707749791833Jul 17Aug 7Aug 27
SMA 50SMA 200

Close
$810.08
RSI (14)
59.1
52W High
$882.86
From 52W High
0.9%

SCORE BREAKDOWN

Quality
75
ROIC
14.4%83.6
ROE
14.0%80.9
GP/Assets
17.0%40.0
Op. Margin
33.1%92.7
FCF/Assets
9.3%84.6
Piotroski
497.9
Int. Cover
50.0x89.3
D/E Ratio
0.09x64.3
Current Ratio
3.33x58.2
Value
46
P/E (TTM)
20.3x58.2
EV/EBITDA
16.1x43.9
P/FCF
22.6x56.8
P/B
3.0x44.6
P/S
5.4x41.0
Div Yield
0.5%9.5
Momentum
66
52W High %
92%86.1
RS 6M
5%68.6
SMA 50/200
0.99x57.7
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-7%32.7

FUNDAMENTALS

Market Cap
$84.9B
P/E (Forward)
—
Gross Margin
44.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of RGO.DE are excluded.

TickerCompanyMkt CapStockRankSignal
RGO.DERegeneron Pharmaceuticals, Inc.(you)$84.9B88Strong Buy
VX1.DEVertex Pharmaceuticals Incorporated$139.0B86Strong Buy
UCB.BRUCB SA$49.2B85Strong Buy
ONCBeOne Medicines AG$42.1B86Strong Buy
ARGX.BRargenx SE$63.4B75Buy
CSL.AXCSL Limited$38.0B79Buy
2269.HKWuXi Biologics (Cayman) Inc.$26.5B82Strong Buy
GMAB.COGenmab A/S$20.5B86Strong Buy
INCYIncyte Corporation$25.9B96Strong Buy
JAZZJazz Pharmaceuticals plc$16.5B92Strong Buy

Peer medians: ROE 1.9% · P/E 24.0x · Gross margin 52.4%

Regeneron Pharmaceuticals, Inc. (RGO.DE): Stock Score Summary

Regeneron Pharmaceuticals, Inc. (RGO.DE) has a MoatMap StockRank of 88/100 based on Quality (75/100), Value (46/100), and Momentum (66/100) factor scores. The current signal is STRONG BUY.

Key Financial Metrics

Price$810.08
Market Cap$84.9B
P/E (TTM)20.28
Price/Book3.02
Return on Equity14.0%
Return on Invested Capital14.4%
Debt/Equity0.09x
Gross Margin44.5%
Operating Margin33.1%
Revenue Growth16.7%
Dividend Yield0.5%
Free Cash Flow$3.8B

Regeneron Pharmaceuticals, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Regeneron Pharmaceuticals, Inc.’s (RGO.DE) StockRank?
MoatMap’s StockRank for Regeneron Pharmaceuticals, Inc. (RGO.DE) is 88/100, with a Strong Buy signal. It is a composite of Quality (75), Value (46), and Momentum (66) factor ranks across MoatMap’s 20,000+ stock universe.
Does Regeneron Pharmaceuticals, Inc. have an economic moat?
Regeneron Pharmaceuticals, Inc. (RGO.DE) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Regeneron Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Regeneron Pharmaceuticals, Inc. (RGO.DE) is Strong Buy, based on a StockRank of 88/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Regeneron Pharmaceuticals, Inc. in?
Regeneron Pharmaceuticals, Inc. (RGO.DE) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksRGO.DE deep dive reportAI ChampionsHow we score stocksSense-check another stock